Completed

EMPEFElucidation and Monitoring Postprandial Endothelial Function

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

high fat meal

+ control meal

Dietary Supplement
Who is being recruted

Cardiovascular Diseases

From 18 to 30 Years
+11 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Interventional
Study Start: October 2008
See protocol details

Summary

Principal SponsorWageningen University
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2008

Actual date on which the first participant was enrolled.

Endothelial dysfunction (ED) is a hallmark for the initial stage of vascular dysfunction and has been associated with diet-related disorders such as cardiovascular disease. This makes prevention of ED an important health target. From previous studies we know that a high-fat (HF) meal (challenge) impairs postprandial endothelial function (EF). Current studies only evaluated the effect of a HF meal on Flow Mediated Dilatation (FMD), a measure of macro vascular EF. This methodology (FMD) however, is time consuming and large variations in reproducibility are reported in literature. The question remains whether other types of macro- and micro vascular EF measurements can be used to observe ED after a HF meal that are more accurate, faster and easier to perform. In addition, it is know that the postprandial phase results in activation of leukocytes. This activation of leukocytes is likely to contribute to ED, but the exact underling mechanism remains unclear.

Official TitleElucidation and Monitoring Postprandial Endothelial Function
NCT00766623
Principal SponsorWageningen University
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

20 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Male

Biological sex of participants that are eligible to enroll.

From 18 to 30 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Cardiovascular Diseases

Criteria

1 inclusion criteria required to participate
male, caucasian

10 exclusion criteria prevent from participating
Body mass index (BMI) < 18 or > 25 kg/m2

Urine glucose concentrations outside normal ranges (>0,25 g/l)

Fasting blood glucose outside the normal range (3 - 5.5 mmol/L)

Tobacco smoking

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

6 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
A high fat milkshake containing 95g of fat

Group II

Experimental
A high fat milkshake containing 95g of fat

Group III

Experimental
A high fat milkshake containing 95g of fat

Group IV

Experimental
Milkshake comparable with a normal breakfast

Group 5

Experimental
Milkshake comparable with a normal breakfast

Group 6

Experimental
Milkshake comparable with a normal breakfast

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Wageningen universiteit division of human

Wageningen, NetherlandsOpen Wageningen universiteit division of human in Google Maps
CompletedOne Study Center